NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»14/10/2009 [Industry news]
Biostar Pharma Wins Patent for Second Hepatitis B Product

Biostar Pharmaceuticals, received a China patent for Aoxing Ganbao, an external use TCM treatment for hepatitis B.

 
Biostar Pharmaceuticals, received a China patent for Aoxing Ganbao, an external use TCM treatment for hepatitis B. Biostar already has name recognition in the hepatitis B sector with its flagship product, Xin Aoxing Oleanolic Acid Capsules. Xin Aoxing Oleanolic capsules, which is the only OTC oral hepatitis treatment product approved by the SFDA, generates about 50% of Biostar’s revenues. The new product, Aoxing Ganbao, is applied topically to fight hepatitis B symptoms by nourishing the liver and reducing inflammation without side effects. Aoxing Ganbao is attached to the patient’s waist with herbs facing the navel. Each dose can be used for one month. Most patients use the product on a long-term basis because hepatitis B is a chronic condition. Biostar said it would set the retail price of Aoxing Ganbao at approximately $20, where its gross margin will be 70%. The patent gives the product protection from competition for 20 years. Biostar said it would continue to develop products for hepatitis B, which affects 10% of China’s population.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.